Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Minerva Neurosciences (NERV) Operating Leases (2019 - 2020)

Minerva Neurosciences filings provide 2 years of Operating Leases readings, the most recent being $16288.0 for Q2 2020.

  • On a quarterly basis, Operating Leases changed N/A to $16288.0 in Q2 2020 year-over-year; TTM through Jun 2020 was $16288.0, a N/A change, with the full-year FY2019 number at $111229.0, changed N/A from a year prior.
  • Operating Leases hit $16288.0 in Q2 2020 for Minerva Neurosciences, down from $64350.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $111229.0 in Q4 2019 to a low of $16288.0 in Q2 2020.